2024 |
Revance Therapeutics Inc
|
President |
- |
- |
2023 |
Revance Therapeutics Inc
|
- |
4.6 M |
76.7 % |
2022 |
Revance Therapeutics Inc
|
President |
2.6 M |
-19.7 % |
2021 |
Revance Therapeutics Inc
|
- |
3.2 M |
0.2 % |
2021 |
Revance Therapeutics Inc
|
President |
3.2 M |
0.2 % |
2020 |
Revance Therapeutics Inc
|
- |
3.2 M |
302.3 % |
2020 |
Revance Therapeutics Inc
|
- |
3.2 M |
302.3 % |
2020 |
Revance Therapeutics Inc
|
Chief Commercial Officer, Aesthetics and Therapeutics |
3.2 M |
302.3 % |
2019 |
Revance Therapeutics Inc
|
- |
801.0 K |
- |
2019 |
Revance Therapeutics Inc
|
- |
801.0 K |
- |
2019 |
Revance Therapeutics Inc
|
Chief Commercial Officer, Aesthetics & Therapeutics |
801.0 K |
- |